Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Profound Medical Corp., a commercial-stage medical device company specializing in AI-powered, MRI-guided, incision-free therapies, announced it will present a business update at the 2026 Bloom Burton & Co. Healthcare Investor Conference. The company highlights its flagship TULSA-PRO platform for prostate therapy and its Sonalleve system for non-sur…